Cas 138374-69-3,Benzeneacetamide, N-[3-(dimethylamino)propyl]-N-[2-[(phenylmethyl)thio]phenyl]-, monohydrochloride

138374-69-3

Post Buying Request

Basic information

Product Name: Benzeneacetamide, N-[3-(dimethylamino)propyl]-N-[2-[(phenylmethyl)thio]phenyl]-, monohydrochloride
Synonyms:
CAS NO:138374-69-3
Molecular Formula: C26H30N2OS.ClH
Molecular Weight: 455.064
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Benzeneacetamide, N-[3-(dimethylamino)propyl]-N-[2-[(phenylmethyl)thio]phenyl]-, monohydrochloride(CAS DataBase Reference)
NIST Chemistry Reference: Benzeneacetamide, N-[3-(dimethylamino)propyl]-N-[2-[(phenylmethyl)thio]phenyl]-, monohydrochloride(138374-69-3)
EPA Substance Registry System: Benzeneacetamide, N-[3-(dimethylamino)propyl]-N-[2-[(phenylmethyl)thio]phenyl]-, monohydrochloride(138374-69-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 138374-69-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

138374-69-3 Suppliers

Recommended suppliers

138374-69-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 138374-69-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,3,7 and 4 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 138374-69:
(8*1)+(7*3)+(6*8)+(5*3)+(4*7)+(3*4)+(2*6)+(1*9)=153
153 % 10 = 3
So 138374-69-3 is a valid CAS Registry Number.

138374-69-3Upstream product

138374-69-3Downstream Products

138374-72-8 N-[2-(Dimethylamino)ethyl]-N-[2-[(phenylmethyl)thio]phenyl]benzeneacetamide, monohydrochloride

138374-69-3Relevant academic research and scientific papers

Pharmaceutical composition and method for treating cardiovascular diseases using substituted anilides and sulfonamides

-

, (2008/06/13)

A novel pharmaceutical composition and method is disclosed for the treatment of cardiovascular diseases, e.g. myocardial ischemia and/or arrhythmia. The method and composition include an effective amount of a compound of the formula STR1 wherein X, Y, R, R1, A, A', m, n, p, p' and B are as defined herein.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 138374-69-3